Glenmark Pharmaceuticals launches TEVIMBRA® in India, boosting access to advanced Immuno-Oncology treatments
Glenmark Pharmaceuticals Ltd., a research-driven global pharmaceutical company, has announced the launch of TEVIMBRA® (tislelizumab) in India, marking its official entry into the immuno-oncology segment.